Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.195 USD | -0.49% | +14.03% | +183.13% |
May. 15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
May. 15 | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+183.13% | 1.07B | |
+7.69% | 113B | |
+10.38% | 106B | |
+0.41% | 22.27B | |
-11.89% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.31% | 17.24B | |
+6.79% | 14.29B | |
+36.28% | 12.52B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Transcript : Arcutis Biotherapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023